Jana Partners’s AbbVie ABBV Stock Holding History

Jana Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-100,000	Closed	-$6.52M	–	47
2017 Q1	$6.52M	Buy	+100,000	New	+$6.29M	0.12%	42

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jana Partners's ABBV Position: Q4 2014 in Review

Jana Partners sold out of AbbVie (ABBV) in Q4 2014, closing a stake of 100,000 shares — an estimated $5.78M sold.

Jana Partners first reported a position in ABBV in Q2 2014 and held it in 2 quarters. The position peaked at $5.78M in Q3 2014. 1,606 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

Jana Partners reported no remaining AbbVie position as of Q4 2014 after selling out during the quarter.
Jana Partners sold 100,000 AbbVie shares in Q4 2014, an estimated $5.78M.
Jana Partners first reported a position in AbbVie in Q2 2014 and held it in 2 quarters.
Jana Partners's AbbVie position peaked at $5.78M in Q3 2014.
1,606 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Jana Partners's 13F filing for Q4 2014, filed 17 Feb 2015.